Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer.

about

Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer.

Item

http://www.wikidata.org/entity/Q42378492

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Survival outcomes based on sys ...... sociated oropharyngeal cancer.

@en

Survival outcomes based on sys ...... sociated oropharyngeal cancer.

@nl

type

Item

label

Survival outcomes based on sys ...... sociated oropharyngeal cancer.

@en

Survival outcomes based on sys ...... sociated oropharyngeal cancer.

@nl

prefLabel

Survival outcomes based on sys ...... sociated oropharyngeal cancer.

@en

Survival outcomes based on sys ...... sociated oropharyngeal cancer.

@nl

P1476

Survival outcomes based on sys ...... sociated oropharyngeal cancer.

@en

P2093

Cherie-Ann O Nathan

http://www.w3.org/2001/XMLSchema#string

Jose M Flores

http://www.w3.org/2001/XMLSchema#string

Oleksandr Ekshyyan

http://www.w3.org/2001/XMLSchema#string

Tara Moore-Medlin

http://www.w3.org/2001/XMLSchema#string

Vikas Mehta

http://www.w3.org/2001/XMLSchema#string

Xiaohui Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Human papillomavirus and survival of patients with oropharyngeal cancer.

Comprehensive genomic characterization of head and neck squamous cell carcinomas

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.

Human papillomavirus 16 oncoprotein regulates the translocation of β-catenin via the activation of epidermal growth factor receptor

Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.

Cetuximab in the treatment of head and neck cancer.

Genomic Copy Number Variations Characterize the Prognosis of Both P16-Positive and P16-Negative Oropharyngeal Squamous Cell Carcinoma After Curative Resection.

Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer.

P304

70907-70915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20197

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29050332

http://www.w3.org/2001/XMLSchema#string

P932

5642607

http://www.w3.org/2001/XMLSchema#string